About Lextro Labs
Lextro Labs is a Healthcare company based in Hyderabad (India) founded in 2022 by Akkina Srinivas Chowdary and Murali K Addepalli. It develops first-in-class biotherapeutics for cancer, autoimmune, metabolic, and infectious diseases using ImCy platform. It operates on a B2B model. Lextro Labs offers products and services including ImCy Platform and Biotherapeutics Pipeline. Its focus areas include Biotechnology, Therapeutics, Disease Treatment and Drug Discovery. Its legal entity in India is Lextro Labs Private Limited (U24290TG2022PTC163976).
Company details
Lextro Labs is a discovery-stage biopharmaceutical company focused on creating innovative biotherapeutics through its ImCy platform, which modulates immune responses and restores homeostasis. It targets diseases such as cancer, autoimmune disorders, metabolic conditions, and infections by identifying dysregulated pathways and developing multi-specific therapies. The company is based in Hyderabad, India, and engages in research, partnerships, and pipeline development to advance healthcare solutions.
- Headquarters Hyderabad, India
- Employees 1
- Founders Akkina Srinivas Chowdary, Murali K Addepalli
- SectorsHealthcare
- Email••••••••
- Website lextrolabs.com
- Social LinkedIn
- Legal Name Lextro Labs Private Limited
- Date of Incorporation 22 Jun, 2022
- Jurisdiction Hyderabad, Telangana, India
- Employee Count1
Associated legal entities of Lextro Labs
Lextro Labs operates through Lextro Labs Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Lextro Labs Private Limited CIN U24290TG2022PTC163976 | Active | 22 Jun 2022 | Hyderabad, Telangana | 4 | View details |
Products & Services of Lextro Labs
Lextro Labs offers a comprehensive portfolio of products and services, including ImCy Platform and Biotherapeutics Pipeline.
Technology for immune modulation and cytotoxicity in disease treatment
Pipeline of therapies for cancer and autoimmune diseases
Board of directors of Lextro Labs Private Limited (Lextro Labs)
Lextro Labs Private Limited is the primary company behind Lextro Labs. The board of Lextro Labs Private Limited currently have 4 directors; the longest-serving is Srinivasa Chowdary Akkina, appointed in 2022.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Srinivasa Chowdary Akkina DIN 02658262 | Director | 22 Jun 2022 | 4 yrs 4 mo | Lextro Labs Private Limited |
| Muni Koteswara Rao Akkina DIN 02576546 | Director | 22 Jun 2022 | 4 yrs 4 mo | Lextro Labs Private Limited |
| Venkata Krishnaji Cherukuri DIN 02576559 | Director | 22 Jun 2022 | 4 yrs 4 mo | Lextro Labs Private Limited |
| Srinivas Suveerji Cherukuri DIN 07248538 | Director | 22 Jun 2022 | 4 yrs 4 mo | Lextro Labs Private Limited |
People of Lextro Labs
2 people are tracked at Lextro Labs (2 in leadership); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
| Co-Founder, Managing Director | Leadership | |
Murali K Addepalli | Co-Founder | Leadership |
Complete people profiles for Lextro Labs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Lextro Labs
Lextro Labs was founded in 2022.
Lextro Labs is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Lextro Labs has 1 employees.
Lextro Labs is a discovery-stage biopharmaceutical company focused on creating innovative biotherapeutics through its ImCy platform, which modulates immune responses and restores homeostasis. It targets diseases such as cancer, autoimmune disorders, metabolic conditions, and infections by identifying dysregulated pathways and developing multi-specific therapies. The company is based in Hyderabad, India, and engages in research, partnerships, and pipeline development to advance healthcare solutions.
Lextro Labs offers ImCy Platform and Biotherapeutics Pipeline.
Lextro Labs operates through Lextro Labs Private Limited.
The legal entities of Lextro Labs currently have 4 directors, including Srinivasa Chowdary Akkina, Muni Koteswara Rao Akkina, Venkata Krishnaji Cherukuri and others.